OncoTherapy Science, Inc. (TYO:4564)
Japan flag Japan · Delayed Price · Currency is JPY
15.00
0.00 (0.00%)
Nov 18, 2026, 10:19 AM JST

OncoTherapy Science Revenue

OncoTherapy Science had revenue of 165.00M JPY in the quarter ending September 30, 2026, a decrease of -28.26%. This brings the company's total for the last twelve months to 712.00M, down -25.52% year-over-year. In the fiscal year ending March 31, 2026, OncoTherapy Science had annual revenue of 808.00M with 7.73% growth. That makes OncoTherapy Science the 40,374th largest company in the world by revenue and 3,819th in Japan.

Revenue (ttm)
712.00M
Revenue Growth
-25.52%
P/S Ratio
8.60
Revenue / Employee
15.48M
Employees
46
Market Cap
6.12B

Revenue Chart

Revenue by Segment

  • Cancer Precision Medicine Related Business 806.20M 99.7%
  • Pharmaceutical Research and Development and Related Businesses 2.64M 0.3%
Fiscal year ended Mar 31, 2026 See the full OncoTherapy Science breakdown

Revenue History

Fiscal Year EndRevenueChangeGrowth
Mar 31, 2026808.00M58.00M7.73%
Mar 31, 2025750.00M140.00M22.95%
Mar 31, 2024610.00M-524.00M-46.21%
Mar 31, 20231.13B-19.00M-1.65%
Mar 31, 20221.15B821.00M247.29%
Mar 31, 2021 Pro Pro Pro
Mar 31, 2020 Pro Pro Pro
Mar 31, 2019 Pro Pro Pro
Mar 31, 2018 Pro Pro Pro
Mar 31, 2017 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.